- Approval Id
- 25230950a9073a70
- Drug Name
- TAMSULOSIN-TEVA PROLONGED RELEASE FILM-COATED TABLET 400MCG
- Product Name
- TAMSULOSIN-TEVA PROLONGED RELEASE FILM-COATED TABLET 400MCG
- Approval Number
- SIN16191P
- Approval Date
- 2021-05-11
- Registrant
- TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
- Licence Holder
- TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Dosage
- **DOSAGE AND ADMINISTRATION**
One tablet daily.
The tablet must be swallowed whole and not be broken, crunched or chewed, as this compromises the prolonged release properties of the tablet for the active ingredient. Tamsulosin hydrochloride tablet can be taken on an empty stomach, or before, with or after food.
- Route Of Administration
- ORAL
- Indication Info
- **INDICATIONS**
For the relief of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
- Contraindications
- **CONTRAINDICATIONS**
- Hypersensitivity to tamsulosin hydrochloride, including drug-induced angioedema or any other component of the product.
- A history of orthostatic hypotension.
- Severe hepatic impairment (Child-Pugh scores >9).
- Severe renal impairment with creatinine clearance of less than 10mL/min.
- Concurrent use of another α1-adrenoceptor inhibitor.
- Atc Code
- G04CA02
- Atc Item Name
- tamsulosin
- Pharma Manufacturer Name
- TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
- Company Detail Path
- /organization/ccec76c3491b1c68/teva-pharmaceutical-investments-singapore-pte-ltd
